<div id="readability-page-1"><p>From January 1, 2026 to January 20, 2026, the company has repurchased 194,144 shares, representing 0.04% for CNY 20 million. With this, the company has completed the repurchase of 194,144 shares, representing 0.04% for CNY 20 million under the buyback announced on December 15, 2025.</p></div>

588130

09995

688331

<p>From January 1, 2026 to January 20, 2026, the company has repurchased 194,144 shares, representing 0.04% for CNY 20 million. With this, the company has completed the repurchase of 194,144 shares, representing 0.04% for CNY 20 million under the buyback announced on December 15, 2025.</p>

marketscreener

ChinaAMC SSE STAR Biology and Medicine ETF

REMEGEN

RemeGen

E Fund CSI Biotechnology Theme ETF

China Merchants CSI Biotechnology Theme ETF

Penghua SSE STAR Biology and Medicine ETF

ChinaAMC CSI Biotechnology Theme ETF

ChinaAMC SSE Health Care ETF Initiating Fund

Guotai CSI Bio-medicine ETF

Ping An CSI Medicine and Medical Device Innovation ETF

Minsheng Royal CSI Biotechnology Theme ETF

Tianhong CNI BIOMEDICINE ETF

E Fund CSI 300 Health Care ETF

Founder Fubon CSI Medicine and Medical Device Innovation ETF

Huaan Hang Seng Biotech ETF

Tranche Update on RemeGen Co., Ltd.'s Equity Buyback Plan announced on December 15, 2025.